...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: ZEN-3694 level up
Reply New Message
Back To Forum List View

Today 10/5/16 marks the completion of the fourth 28-day time period of the trial. So in theory, they should be starting on the 5th dosing level for the ZEN-3694 mCRPC trial. At some point soon, according to their June upate, they should be starting the ZEN-3694/enzalutamide combo trial.

BearDownAZ

2 Recommendations
Icon president Re: ZEN-3694 level up
1
SanFrancisco99
Oct 05, 2016 03:20PM
Re: ZEN-3694 level up

Hartland
Oct 06, 2016 05:57AM
Icon president Re: ZEN-3694 level up
2
BearDownAZ
Oct 06, 2016 10:10AM
Reply New Message
Back To Forum List View
Share
Share
New Message
Please login to post a reply